menu

Medical Program: The DEA’s Adjustment to Schedule II Rules Amid COVID-19

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

The DEA’s Adjustment to Schedule II Rules Amid COVID-19

close
The DEA’s Adjustment to Schedule II Rules Amid COVID-19
Restart
Resume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    The Drug Enforcement Administration (DEA) issued a new guidance for the issuance of oral Schedule II prescriptions in light of the COVID-19 pandemic and nationwide public health emergency. Pharmacist Dr. Linda Bernstein details the DEA’s temporary exceptions to the regulations to ease prescribing and dispensing of these controlled substances during this challenging time.                                                                              

    Published April 24, 2020

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    The Drug Enforcement Administration (DEA) issued a new guidance for the issuance of oral Schedule II prescriptions in light of the COVID-19 pandemic and nationwide public health emergency. Pharmacist Dr. Linda Bernstein details the DEA’s temporary exceptions to the regulations to ease prescribing and dispensing of these controlled substances during this challenging time.                                                                              

    Published April 24, 2020

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 8/9/20